Illicit drug overdose deaths in Vancouver’s Downtown Eastside declined dramatically after the establishment of Insite, North America’s first supervised injection facility, according to the findings of a groundbreaking new study published today in The Lancet, a leading medical journal.
In the first peer-reviewed study to assess the impact of supervised injection sites on overdose mortality, researchers at the Urban Health Research Initiative (UHRI), a program of the BC Centre for Excellence in HIV/AIDS (BC-CfE), observed a 35 per cent reduction in overdose deaths in the immediate vicinity of Insite following its opening in September 2003. By contrast, overdose deaths in the rest of Vancouver declined only nine per cent over the same period. No overdose deaths have been recorded at Insite since the facility’s opening.
If you would like to request an intevriew with one of the authors of the study, please contact Mahafrine Petigara at firstname.lastname@example.org or 604-623-3007.
Full news release